Arakoda
Payments companies reported to CMS as associated with Arakoda. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Arakoda, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Arakoda
These are the largest totals companies reported as associated with Arakoda. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Thomas Moorcroft | Hebron, CT | Family Medicine | $1,286.10 |
| Denis Bouboulis | Darien, CT | Allergy & Immunology | $986.10 |
| Shannon Delaney | New York, NY | Child & Adolescent Psychiatry | $986.10 |
| Richard Horowitz | Hyde Park, NY | Internal Medicine | $986.10 |
| Virginia Savely | Bethesda, MD | Family | $986.10 |
Prescribed Arakoda?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.